Predictive factors for node involvement in papillary thyroid carcinoma. Univariate and multivariate analyses

European Journal of Cancer

Volumn 35, Issue 3, 1999, Pages 420-423

  Mirallie E ^a   Sagan, C ^a   Hamy, A ^a   Paineau, J ^a   Kahn, X ^a   Le Neel J C ^a   Auget, J L ^a   Murat, A ^b   Joubert, M ^a   Le Bodic, M F ^a   Visset, J ^a  

^a UNIVERSITÉ DE NANTES   (France)

^b NANTES UNIVERSITY HOSPITAL   (France)

Author keywords

Lymph node dissection; Lymph node metastases; Papillary thyroid carcinoma

Indexed keywords

ARTICLE; FEMALE; HIGH RISK PATIENT; HUMAN; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PATIENT SELECTION; PRIORITY JOURNAL; PROGNOSIS; RISK ASSESSMENT; THYROID CARCINOMA; TREATMENT PLANNING; TUMOR VOLUME;

ADOLESCENT; ADULT; ANALYSIS OF VARIANCE; CARCINOMA, PAPILLARY; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; LYMPH NODE EXCISION; LYMPH NODES; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; RETROSPECTIVE STUDIES; THYROID NEOPLASMS; THYROIDECTOMY;

EID: 0033106380     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0959-8049(98)00399-2     Document Type: Article

References (23)

1. Ozaki O., Ito K., Kobayashi K., Suzuki A., Manabe Y. Modified neck dissection for patients with nonadvanced, differentiated carcinoma of the thyroid. World J. Surg. 12:1988;825-829.
2. Mazzaferri E.L., Jhiang S.M. Long-term impact of initial surgical and medical therapy on papillary and follicular thyroid cancer. Am. J. Med. 97:1994;418-428.
3. Shaha A.R., Shah J.P., Loree T.R. Patterns of nodal and distant metastasis based on histologic varieties in differentiated carcinoma of the thyroid. Am. J. Surg. 172:1996;692-694.
4. Tisell L.E., Nilsson B., Mölne J., et al. Improved survival of patients with papillary thyroid cancer after surgical microdissection. World J. Surg. 20:1996;854-859.
5. Scheumann G.F.W., Gimm O., Wegener G., Hundeshagen H., Dralle H. Prognostic significance and surgical management of locoregional lymph node metastases in papillary thyroid cancer. World J. Surg. 18:1994;559-568.
6. Noguchi M., Kumaki T., Taniya T., Miyazaki I. Bilateral cervical lymph node metastases in well-differentiated thyroid cancer. Arch. Surg. 125:1990;804-806.
7. Bergamaschi R., Becouarn G., Ronceray J., Arnaud J.P. Morbidity of thyroid surgery. Am. J. Surg. 176:1998;71-75.
8. Frankenthaler R.A., Sellin R.V., Cangir A., Goepfert H. Lymph node metestasis from papillary-follicular thyroid carcinoma in young patients. Am. J. Surg. 160:1990;341-343.
9. Sellers M., Beenken S., Blankenship A., et al. Prognostic significance of cervical lymph node metastases in differentiated thyroid cancer. Am. J. Surg. 164:1992;578-581.
10. Simon D., Goretzki P.E., Witte J., Röher H.D. Incidence of regional recurrence guiding radicality in differentiated thyroid carcinoma. World J. Surg. 20:1996;860-866.
11. McHenry C.R., Rosen I.B., Walfish P.G. Prospective management of nodal metastases in differentiated thyroid carcinoma. Am. J. Surg. 162:1991;353-356.
12. DeGroot L.J., Kaplan E.L., McCormick M., Straus F.H. Natural history, treatment, and course of papillary thyroid carcinoma. J. Clin. Endocrinol. Metab. 71:1990;414-424.
13. Moreno-Egea A., Rodriguez-Gonzalez J.M., Sola-Perez J., Soria-Cogollos T., Parrilla-Paricio P. Multivariate analysis of histopathological features as prognostic factors in patients with papillary thyroid carcinoma. Br. J. Surg. 82:1995;1092-1094.
14. Akslen L.A., Myking A.O., Salvesen H., Varhaug J.E. Prognostic importance of various clinicopathological features in papillary thyroid carcinoma. Eur. J. Cancer. 29A:1993;44-51.
15. Ahuja S., Ernst H., Lenz K. Papillary thyroid carcinoma: occurrence and types of lymph node metastases. J. Endocrinol. Invest. 14:1991;543-549.
16. Zimmerman D., Hay I.D., Gough I.R., et al. Papillary thyroid carcinoma in children and adults: long-term follow-up of 1039 patients conservatively treated at one institution during three decades. Surgery. 104:1988;1157-1166.
17. Carcangiu M.L., Zampi G., Pupi A., Castagnoli A., Rosai J. Papillary carcinoma of the thyroid. A clinicopathologic study of 241 cases treated at the University of Florence, Italy. Cancer. 55:1985;805-828.
18. Hay I.D., Grant C.S., van Heerden J.A., Goellner J.R., Ebersold J.R., Bergstralh E.J. Papillary thyroid microcarcinoma: a study of 535 cases observed in a 50-year period. Surgery. 112:1992;1139-1147.
19. Henry J.F., Audiffret J., Denizot A., Bordigoni L., de Micco C. Envahissement intra-thyroïdien et ganglionnaire des cancers thyroïdiens différenciés. Rev. Franç Endocrinol. Clin. 30:1989;13-20.
20. Schlumberger M. Papillary and follicular thyroid carcinoma. N. Engl. J. Med. 338:1998;297-306.
21. Mazzaferri E. Thyroid remnant 131-I ablation for papillary and follicular thyroid carcinoma. Thyroid. 7:1997;265-271.
22. Tubiana M., Schlumberger M., Rougier P., et al. Long term results and prognostic factors in patients with differentiated thyroid carcinoma. Cancer. 55:1985;794-804.
23. Travagli J.P., Cailleux A.F., Ricard M., et al. Combination of radioiodine (131-I) and probe-guided surgery for persistent or recurrent thyroid carcinoma. J Clin Endocrinol Metab. 83:1998;2675-2680.